Find Research Outputs

Search in all content

Filters for Publications

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Thomas Geisbert
2014

Vaccines and antivirals for filoviruses

Mire, C. & Geisbert, T., Jan 1 2014, Biology and Pathogenesis of Rhabdo- and Filoviruses. World Scientific Publishing Co., p. 587-620 34 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations
2017

Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses

Daaboul, G. G., Freedman, D. S., Scherr, S. M., Carter, E., Rosca, A., Bernstein, D., Mire, C. E., Agans, K. N., Hoenen, T., Geisbert, T. W., Selim Ünlü, M. & Connor, J. H., Jun 2017, In : PloS one. 12, 6, e0179728.

Research output: Contribution to journalArticle

5 Scopus citations
2015

Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines

Marzi, A., Kercher, L., Marceau, J., York, A., Callsion, J., Gardner, D. J., Geisbert, T. W. & Feldmann, H., Oct 1 2015, In : Journal of Infectious Diseases. 212, p. S404-S409

Research output: Contribution to journalArticle

14 Scopus citations
2020

Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization

Gilchuk, P., Murin, C. D., Milligan, J. C., Cross, R. W., Mire, C. E., Ilinykh, P. A., Huang, K., Kuzmina, N., Altman, P. X., Hui, S., Gunn, B. M., Bryan, A. L., Davidson, E., Doranz, B. J., Turner, H. L., Alkutkar, T., Flinko, R., Orlandi, C., Carnahan, R., Nargi, R. & 13 others, Bombardi, R. G., Vodzak, M. E., Li, S., Okoli, A., Ibeawuchi, M., Ohiaeri, B., Lewis, G. K., Alter, G., Bukreyev, A., Saphire, E. O., Geisbert, T. W., Ward, A. B. & Crowe, J. E., Feb 18 2020, In : Immunity. 52, 2, p. 388-403.e12

Research output: Contribution to journalArticle

Open Access
4 Scopus citations
2018

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates

Woolsey, C., Geisbert, J. B., Matassov, D., Agans, K. N., Borisevich, V., Cross, R. W., Deer, D. J., Fenton, K. A., Eldridge, J. H., Mire, C. E. & Geisbert, T. W., Nov 22 2018, In : Journal of Infectious Diseases. 218, p. S582-S587

Research output: Contribution to journalArticle

6 Scopus citations
2017

Therapeutic treatment of marburg and ravn virus infection in nonhuman primates with a human monoclonal antibody

Mire, C. E., Geisbert, J. B., Borisevich, V., Fenton, K. A., Agans, K. N., Flyak, A. I., Deer, D. J., Steinkellner, H., Bohorov, O., Bohorova, N., Goodman, C., Hiatt, A., Kim, D. H., Pauly, M. H., Velasco, J., Whaley, K. J., Crowe, J. E., Zeitlin, L. & Geisbert, T. W., Apr 5 2017, In : Science Translational Medicine. 9, 384, eaai8711.

Research output: Contribution to journalArticle

29 Scopus citations
2019

Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization

Hastie, K. M., Cross, R. W., Harkins, S. S., Zandonatti, M. A., Koval, A. P., Heinrich, M. L., Rowland, M. M., Robinson, J. E., Geisbert, T. W., Garry, R. F., Branco, L. M. & Saphire, E. O., Aug 8 2019, In : Cell. 178, 4, p. 1004-1015.e14

Research output: Contribution to journalArticle

1 Scopus citations
2014

Lassa Fever in Post-Conflict Sierra Leone

Shaffer, J. G., Grant, D. S., Schieffelin, J. S., Boisen, M. L., Goba, A., Hartnett, J. N., Levy, D. C., Yenni, R. E., Moses, L. M., Fullah, M., Momoh, M., Fonnie, M., Fonnie, R., Kanneh, L., Koroma, V. J., Kargbo, K., Ottomassathien, D., Muncy, I. J., Jones, A. B., Illick, M. M. & 31 others, Kulakosky, P. C., Haislip, A. M., Bishop, C. M., Elliot, D. H., Brown, B. L., Zhu, H., Hastie, K. M., Andersen, K. G., Gire, S. K., Tabrizi, S., Tariyal, R., Stremlau, M., Matschiner, A., Sampey, D. B., Spence, J. S., Cross, R. W., Geisbert, J. B., Folarin, O. A., Happi, C. T., Pitts, K. R., Geske, F. J., Geisbert, T. W., Saphire, E. O., Robinson, J. E., Wilson, R. B., Sabeti, P. C., Henderson, L. A., Khan, S. H., Bausch, D. G., Branco, L. M. & Garry, R. F., Mar 2014, In : PLoS neglected tropical diseases. 8, 3, e2748.

Research output: Contribution to journalArticle

88 Scopus citations
2017

Persistence of Ebola virus RNA in seminal fluid

Geisbert, T., Jan 1 2017, In : The Lancet Global Health. 5, 1, p. e12-e13

Research output: Contribution to journalComment/debate

2013

Animal models for highly pathogenic emerging viruses

Safronetz, D., Geisbert, T. W. & Feldmann, H., Apr 2013, In : Current Opinion in Virology. 3, 2, p. 205-209 5 p.

Research output: Contribution to journalReview article

22 Scopus citations
2019

The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus

Jasenosky, L. D., Cadena, C., Mire, C. E., Borisevich, V., Haridas, V., Ranjbar, S., Nambu, A., Bavari, S., Soloveva, V., Sadukhan, S., Cassell, G. H., Geisbert, T. W., Hur, S. & Goldfeld, A. E., Sep 27 2019, In : iScience. 19, p. 1279-1290 12 p.

Research output: Contribution to journalArticle

Open Access
20 Scopus citations
2018

Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms

Warfield, K. L., Howell, K. A., Vu, H., Geisbert, J., Wong, G., Shulenin, S., Sproule, S., Holtsberg, F. W., Leung, D. W., Amarasinghe, G. K., Swenson, D. L., Bavari, S., Kobinger, G. P., Geisbert, T. & Aman, M. J., Nov 22 2018, In : The Journal of infectious diseases. 218, 5, p. S553-S564

Research output: Contribution to journalArticle

9 Scopus citations
2015

Vaccination with a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge with a Lethal Dose of Ebola Virus

Matassov, D., Marzi, A., Latham, T., Xu, R., Ota-Setlik, A., Feldmann, F., Geisbert, J. B., Mire, C. E., Hamm, S., Nowak, B., Egan, M. A., Geisbert, T. W., Eldridge, J. H., Feldmann, H. & Clarke, D. K., Oct 1 2015, In : Journal of Infectious Diseases. 212, p. S443-S451

Research output: Contribution to journalArticle

31 Scopus citations

Development of Prototype Filovirus Recombinant Antigen Immunoassays

Boisen, M. L., Oottamasathien, D., Jones, A. B., Millett, M. M., Nelson, D. S., Bornholdt, Z. A., Fusco, M. L., Abelson, D. M., Oda, S. I., Hartnett, J. N., Rowland, M. M., Heinrich, M. L., Akdag, M., Goba, A., Momoh, M., Fullah, M., Baimba, F., Gbakie, M., Safa, S., Fonnie, R. & 14 others, Kanneh, L., Cross, R. W., Geisbert, J. B., Geisbert, T. W., Kulakosky, P. C., Grant, D. S., Shaffer, J. G., Schieffelin, J. S., Wilson, R. B., Saphire, E. O., Branco, L. M., Garry, R. F., Khan, S. H. & Pitts, K. R., Oct 1 2015, In : Journal of Infectious Diseases. 212, p. S359-S367

Research output: Contribution to journalArticle

12 Scopus citations
2011

Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy

Marzi, A., Ebihara, H., Callison, J., Groseth, A., Williams, K. J., Geisbert, T. W. & Feldmann, H., Nov 1 2011, In : Journal of Infectious Diseases. 204, SUPPL. 3, p. S1066-S1074

Research output: Contribution to journalArticle

69 Scopus citations
2015

Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses

Meyer, M., Garron, T., Lubaki, N. M., Mire, C. E., Fenton, K. A., Klages, C., Olinger, G. G., Geisbert, T. W., Collins, P. L. & Bukreyev, A., Aug 3 2015, In : Journal of Clinical Investigation. 125, 8, p. 3241-3255 15 p.

Research output: Contribution to journalArticle

44 Scopus citations
2019
Open Access
2020

Early transcriptional changes within liver, adrenal gland, and lymphoid tissues significantly contribute to Ebola virus pathogenesis in cynomolgus macaques

Jankeel, A., Menicucci, A. R., Woolsey, C., Fenton, K., Mendoza, N., Versteeg, K., Cross, R. W., Geisbert, T. W. & Messaoudi, I., Jun 1 2020, In : Journal of virology. 94, 11, e00250-20.

Research output: Contribution to journalArticle

2011

Recombinant vesicular stomatitis virus-based vaccines against Ebola and marburg virus infections

Geisbert, T. W. & Feldmann, H., Nov 1 2011, In : Journal of Infectious Diseases. 204, SUPPL. 3, p. S1075-S1081

Research output: Contribution to journalArticle

123 Scopus citations
2019

An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

Dang, H. V., Chan, Y. P., Park, Y. J., Snijder, J., Da Silva, S. C., Vu, B., Yan, L., Feng, Y. R., Rockx, B., Geisbert, T. W., Mire, C. E., Broder, C. C. & Veesler, D., Oct 1 2019, In : Nature Structural and Molecular Biology. 26, 10, p. 980-987 8 p.

Research output: Contribution to journalArticle

6 Scopus citations
2017

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants

Versteeg, K., Menicucci, A. R., Woolsey, C., Mire, C. E., Geisbert, J. B., Cross, R. W., Agans, K. N., Jeske, D., Messaoudi, I. & Geisbert, T. W., Dec 1 2017, In : Scientific reports. 7, 1, 9730.

Research output: Contribution to journalArticle

13 Scopus citations
2015

Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig

Cross, R., Fenton, K. A., Geisbert, J. B., Mire, C. & Geisbert, T., Oct 1 2015, In : Journal of Infectious Diseases. 212, p. S305-S315

Research output: Contribution to journalArticle

29 Scopus citations
2013

A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques

Safronetz, D., Strong, J. E., Feldmann, F., Haddock, E., Sogoba, N., Brining, D., Geisbert, T. W., Scott, D. P. & Feldmann, H., Apr 15 2013, In : Journal of Infectious Diseases. 207, 8, p. 1316-1327 12 p.

Research output: Contribution to journalArticle

26 Scopus citations
2015

The broad-spectrum antiviral favipiravir protects Guinea pigs from lethal Lassa virus infection post-disease onset

Safronetz, D., Rosenke, K., Westover, J. B., Martellaro, C., Okumura, A., Furuta, Y., Geisbert, J., Saturday, G., Komeno, T., Geisbert, T. W., Feldmann, H. & Gowen, B. B., Oct 12 2015, In : Scientific reports. 5, 14775.

Research output: Contribution to journalArticle

56 Scopus citations
2014

Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells

Shabman, R. S., Jabado, O. J., Mire, C. E., Stockwell, T. B., Edwards, M., Mahajan, M., Geisbert, T. W. & Basler, C. F., 2014, In : mBio. 5, 6, p. e02011

Research output: Contribution to journalArticle

2013

Interferon- therapy prolongs survival in rhesus macaque models of ebola and marburg hemorrhagic fever

Smith, L. M., Hensley, L. E., Geisbert, T. W., Johnson, J., Stossel, A., Honko, A., Yen, J. Y., Geisbert, J., Paragas, J., Fritz, E., Olinger, G., Young, H. A., Rubins, K. H. & Karp, C. L., Jul 15 2013, In : Journal of Infectious Diseases. 208, 2, p. 310-318 9 p.

Research output: Contribution to journalArticle

77 Scopus citations
2011

CD8 + cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

Sullivan, N. J., Hensley, L., Asiedu, C., Geisbert, T. W., Stanley, D., Johnson, J., Honko, A., Olinger, G., Bailey, M., Geisbert, J. B., Reimann, K. A., Bao, S., Rao, S., Roederer, M., Jahrling, P. B., Koup, R. A. & Nabel, G. J., Sep 1 2011, In : Nature Medicine. 17, 9, p. 1128-1131 4 p.

Research output: Contribution to journalArticle

146 Scopus citations
2014

Marburg and Ebola Hemorrhagic Fevers (Filoviruses)

Geisbert, T., Aug 28 2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier Inc., Vol. 2. p. 1995-1999.e1

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations
2015

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses

Safronetz, D., Mire, C., Rosenke, K., Feldmann, F., Haddock, E., Geisbert, T. & Feldmann, H., Apr 17 2015, In : PLoS neglected tropical diseases. 9, 4, e0003736.

Research output: Contribution to journalArticle

50 Scopus citations
2014

Viral-vectored vaccines to control pathogenic filoviruses

Mire, C. & Geisbert, T., Jul 1 2014, Novel Technologies for Vaccine Development. Springer-Verlag Wien, Vol. 9783709118184. p. 33-60 28 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations
2011

Pathogenesis of marburg hemorrhagic fever in cynomolgus macaques

Hensley, L. E., Alves, D. A., Geisbert, J. B., Fritz, E. A., Reed, C., Larsen, T. & Geisbert, T. W., Nov 1 2011, In : Journal of Infectious Diseases. 204, SUPPL. 3, p. S1021-S1031

Research output: Contribution to journalArticle

54 Scopus citations
2020

Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated with Cell-Mediated and Humoral Immunity

Prasad, A. N., Woolsey, C., Geisbert, J. B., Agans, K. N., Borisevich, V., Deer, D. J., Mire, C. E., Cross, R. W., Fenton, K. A., Broder, C. C. & Geisbert, T. W., May 11 2020, In : Journal of Infectious Diseases. 221, p. S436-S447

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2013

Filoviridae: Marburg and ebola viruses

Feldmann, H., Sanchez, A. & Geisbert, T., May 21 2013, Fields Virology: Sixth Edition. Wolters Kluwer Health Adis (ESP), Vol. 1.

Research output: Chapter in Book/Report/Conference proceedingChapter

81 Scopus citations
2017

Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo

Warfield, K. L., Warren, T. K., Qiu, X., Wells, J., Mire, C. E., Geisbert, J. B., Stuthman, K. S., Garza, N. L., Van Tongeren, S. A., Shurtleff, A. C., Agans, K. N., Wong, G., Callahan, M. V., Geisbert, T. W., Klose, B., Ramstedt, U. & Treston, A. M., Feb 1 2017, In : Antiviral research. 138, p. 22-31 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

First Ebola virus vaccine to protect human beings?

Geisbert, T., Feb 4 2017, In : The Lancet. 389, 10068, p. 479-480 2 p.

Research output: Contribution to journalComment/debate

7 Scopus citations
2018

Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans

Cross, R. W., Speranza, E., Borisevich, V., Widen, S. G., Wood, T. G., Shim, R. S., Adams, R. D., Gerhardt, D. M., Bennett, R. S., Honko, A. N., Johnson, J. C., Hensley, L. E., Geisbert, T. W. & Connor, J. H., Nov 22 2018, In : Journal of Infectious Diseases. 218, p. S486-S495

Research output: Contribution to journalArticle

8 Scopus citations
2020

Structure and characterization of crimean-congo hemorrhagic fever virus GP38

Mishra, A. K., Moyer, C. L., Abelson, D. M., Deer, D. J., El Omari, K., Duman, R., Lobel, L., Lutwama, J. J., Dye, J. M., Wagner, A., Chandran, K., Cross, R. W., Geisbert, T. W., Zeitlin, L., Bornholdt, Z. A. & McLellan, J. S., Mar 1 2020, In : Journal of virology. 94, 8, e02005-19.

Research output: Contribution to journalArticle

Open Access
2015

Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in sierra leone prior to the 2014 outbreak

Boisen, M. L., Schieffelin, J. S., Goba, A., Oottamasathien, D., Jones, A. B., Shaffer, J. G., Hastie, K. M., Hartnett, J. N., Momoh, M., Fullah, M., Gabiki, M., Safa, S., Zandonatti, M., Fusco, M., Bornholdt, Z., Abelson, D., Gire, S. K., Andersen, K. G., Tariyal, R., Stremlau, M. & 13 others, Cross, R. W., Geisbert, J. B., Pitts, K. R., Geisbert, T. W., Kulakoski, P., Wilson, R. B., Henderson, L., Sabeti, P. C., Grant, D. S., Garry, R. F., Saphire, E. O., Branco, L. M. & Khan, S. H., Feb 1 2015, In : Viral Immunology. 28, 1, p. 19-31 13 p.

Research output: Contribution to journalArticle

27 Scopus citations
2011

Infectious disease: A neutralizing human monoclonal antibody protects African green monkeys from Hendra virus challenge

Bossart, K. N., Geisbert, T. W., Feldmann, H., Zhu, Z., Feldmann, F., Geisbert, J. B., Yan, L., Feng, Y. R., Brining, D., Scott, D., Wang, Y., Dimitrov, A. S., Callison, J., Chan, Y. P., Hickey, A. C., Dimitrov, D. S., Broder, C. C. & Rockx, B., Oct 19 2011, In : Science Translational Medicine. 3, 105, 105ra103.

Research output: Contribution to journalArticle

90 Scopus citations
2018

Single-dose trivalent VesiculoVax vaccine protects macaques from lethal Ebolavirus and Marburgvirus challenge

Matassov, D., Mire, C. E., Latham, T., Geisbert, J. B., Xu, R., Ota-Setlik, A., Agans, K. N., Kobs, D. J., Wendling, M. Q. S., Burnaugh, A., Rudge, T. L., Sabourin, C. L., Egan, M. A., Clarke, D. K., Geisbert, T. W. & Eldridge, J. H., Feb 1 2018, In : Journal of virology. 92, 3, e01190-17.

Research output: Contribution to journalArticle

12 Scopus citations
2019

Antibody therapy for Lassa fever

Cross, R. W., Hastie, K. M., Mire, C. E., Robinson, J. E., Geisbert, T. W., Branco, L. M., Ollmann Saphire, E. & Garry, R. F., Aug 2019, In : Current Opinion in Virology. 37, p. 97-104 8 p.

Research output: Contribution to journalReview article

1 Scopus citations
2020

A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys

Prasad, A. N., Agans, K. N., Sivasubramani, S. K., Geisbert, J. B., Borisevich, V., Mire, C. E., Lawrence, W. S., Fenton, K. A. & Geisbert, T. W., May 11 2020, In : Journal of Infectious Diseases. 221, p. S431-S435

Research output: Contribution to journalArticle

1 Scopus citations
2018

Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever

Boisen, M. L., Hartnett, J. N., Shaffer, J. G., Goba, A., Momoh, M., Sandi, J. D., Fullah, M., Nelson, D. K. S., Bush, D. J., Rowland, M. M., Heinrich, M. L., Koval, A. P., Cross, R. W., Barnes, K. G., Lachenauer, A. E., Lin, A. E., Nekoui, M., Kotliar, D., Winnicki, S. M., Siddle, K. J. & 18 others, Gbakie, M., Fonnie, M., Koroma, V. J., Kanneh, L., Kulakosky, P. C., Hastie, K. M., Wilson, R. B., Andersen, K. G., Folarin, O. O., Happi, C. T., Sabeti, P. C., Geisbert, T. W., Saphire, E. O., Khan, S. H., Grant, D. S., Schieffelin, J. S., Branco, L. M. & Garry, R. F., Dec 1 2018, In : Scientific reports. 8, 1, 5939.

Research output: Contribution to journalArticle

10 Scopus citations
2017

The gap between animal and human Ebola virus disease

Muñoz-Fontela, C. & Geisbert, T., Feb 1 2017, In : Future Virology. 12, 2, p. 61-65 5 p.

Research output: Contribution to journalComment/debate

Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

Mire, C. E., Cross, R. W., Geisbert, J. B., Borisevich, V., Agans, K. N., Deer, D. J., Heinrich, M. L., Rowland, M. M., Goba, A., Momoh, M., Boisen, M. L., Grant, D. S., Fullah, M., Khan, S. H., Fenton, K. A., Robinson, J. E., Branco, L. M., Garry, R. F. & Geisbert, T. W., Oct 1 2017, In : Nature Medicine. 23, 10, p. 1146-1149 4 p.

Research output: Contribution to journalArticle

36 Scopus citations
2014

Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus

Garamszegi, S., Yen, J. Y., Honko, A. N., Geisbert, J. B., Rubins, K. H., Geisbert, T. W., Xia, Y., Hensley, L. E. & Connor, J. H., Jul 2014, In : PLoS neglected tropical diseases. 8, 7, e3061.

Research output: Contribution to journalArticle

13 Scopus citations

The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway

Edwards, M. R., Johnson, B., Mire, C. E., Xu, W., Shabman, R. S., Speller, L. N., Leung, D. W., Geisbert, T. W., Amarasinghe, G. K. & Basler, C. F., Mar 27 2014, In : Cell Reports. 6, 6, p. 1017-1025 9 p.

Research output: Contribution to journalArticle

61 Scopus citations
2019

A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge

Woolsey, C., Menicucci, A. R., Cross, R. W., Luthra, P., Agans, K. N., Borisevich, V., Geisbert, J. B., Mire, C. E., Fenton, K. A., Jankeel, A., Anand, S., Ebihara, H., Geisbert, T. W., Messaoudi, I. & Basler, C. F., Sep 17 2019, In : Cell Reports. 28, 12, p. 3032-3046.e6

Research output: Contribution to journalArticle

Open Access
3 Scopus citations
2011

Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with bundibugyo ebolavirus

Falzarano, D., Feldmann, F., Grolla, A., Leung, A., Ebihara, H., Strong, J. E., Marzi, A., Takada, A., Jones, S., Gren, J., Geisbert, J., Jones, S. M., Geisbert, T. W. & Feldmann, H., Nov 1 2011, In : Journal of Infectious Diseases. 204, SUPPL. 3, p. S1082-S1089

Research output: Contribution to journalArticle

40 Scopus citations
2019

Use of reverse genetics to inform Ebola outbreak responses

Cross, R. W. & Geisbert, T. W., Sep 2019, In : The Lancet Infectious Diseases. 19, 9, p. 925-927 3 p.

Research output: Contribution to journalComment/debate

1 Scopus citations